Diseases Market Research

Reportbuyer.com helps you stay ahead with advanced reports on Diseases. Information includes Competitive Positioning, Stakeholder Opinions and Future Market Watch.

Stay up-to-date with new products added to this category

Results 101 - 200 of 433 go to 1st page

first

previous 1 2 3 4 5 next

last

Title	Date	Price
China Dermatosis Drug Market Report The Chinese Hospital Cancer Drug Utilization	Feb 2009	£4,950
Interleukin-1 (IL-1) and IL-1 receptor (IL-1R) Antagonists Competitor Analysis	Feb 2009	£89
Global Dialysis Market Report: 2009 Edition	Feb 2009	£515
Diabetes Drug Discoveries 2009: what the future holds	Feb 2009	£795
Chinese Markets for Lung Cancer Treatment Drugs	Feb 2009	£2,405
Cancer Therapies	Feb 2009	£2,375
Wet Age-Related Macular Degeneration (AMD) Competitor Analysis	Feb 2009	£270
Neurodegenerative Market Forecast to 2013	Feb 2009	£6,185
Global Spine Market Report: 2009 Edition	Feb 2009	£485
Inflammatory Bowel Diseases World Market Report 2009-2024	Feb 2009	£1,499
Chinese Markets for Breast Cancer Treatment Drugs	Feb 2009	£2,405
World Diabetes Market Analysis 2009-2023	Feb 2009	£1,499
Global HIV Market: An Analysis	Feb 2009	£425
Analytical Tool - Apoptosis in Oncology	Jan 2009	£2,835
Cancer Market Trends 2008 - 2012	Jan 2009	£1,100
Protein Kinase C (PKC) Inhibitors Competitor Analysis	Jan 2009	£180
Lymphoma Drug Pipeline Update 2009	Jan 2009	£1,370
MarketWatch: CNS	Jan 2009	£120
Anti-Infective Peptides Competitor Analysis	Jan 2009	£270
Analytical Tool - Prostate Cancer A Therapeutic & Competitive Insight	Jan 2009	£2,835
MarketWatch: Cancer	Jan 2009	£120
CD20 Antibodies Competitor Analysis	Jan 2009	£180
Analytical Tool - Breast Cancer	Jan 2009	£2,835
Stakeholder Opinions: Cancer Cachexia - Higher profile needed to unlock market potential of neglected syndrome	Jan 2009	£2,285
Lung Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Pancreatic Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Liver Cancer Drug Pipeline Update 2009	Jan 2009	£915
C5a-R Antagonists Competitor Analysis	Jan 2009	£110
China Diabetes Drug Market Report The Chinese Hospital Cancer Drug Utilization	Jan 2009	£4,950
Pipeline Insight: Cancer Overview Gastrointestinal, Skin, Sarcomas	Jan 2009	£6,950
Breast Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Ovarian Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Antibodies in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Immunotherapy in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,825
PTH Receptor Agonists Competitor Analysis	Jan 2009	£135
Colorectal Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Apoptosis in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Angiogenesis in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Bladder Cancer Drug Pipeline Update 2009	Jan 2009	£915
Analytical Tool - Melanoma	Jan 2009	£2,835
Melanoma Drug Pipeline Update 2009	Jan 2009	£1,370
Hematological Cancers Drug Pipeline Update 2009	Jan 2009	£1,825
Leukemia Drug Pipeline Update 2009	Jan 2009	£1,370
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2009	Jan 2009	£1,370
Brain Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
Prostate Cancer: Drug Pipeline Update 2009	Jan 2009	£1,370
Renal Cancer Drug Pipeline Update 2009	Jan 2009	£1,370
U.S. Markets for Addiction & Substance Abuse Treatment	Jan 2009	£2,915
U.S. Cancer Molecular Diagnostics Markets	Dec 2008	£3,605
Neurodegenerative Diseases Next-Generation Drugs for Four Major Disorders	Dec 2008	£2,255
Opportunities Assessment for Diabetes Therapeutics: South Korea	Dec 2008	£3,605
Strategic Analysis of the South African HMI Markets	Dec 2008	£3,605
Opportunities Assessment for Diabetes Therapeutics - Australia	Dec 2008	£3,605
U.S. Non-Glaucoma Ophthalmic Pharmaceuticals Market	Dec 2008	£3,605
China Anti-Cancer Drug Market Report The Chinese Hospital Cancer Drug Utilization	Dec 2008	£4,950
Opportunities Assessment for Diabetes Therapeutics Market-Taiwan	Dec 2008	£3,605
European Point of Care (POC) Infectious Disease Market	Dec 2008	£3,605
European Diabetes Diagnostics Market	Dec 2008	£3,910
Stakeholder Opinions: Restless Legs Syndrome Novel drugs to prosper as lifecycle management strategies fail	Nov 2008	£4,635
Sodium-dependent glucose (co-) transporter (SGLT) Inhibitors Competitor Analysis	Nov 2008	£89
Cannabinoid CB1 receptor antagonists Competitor Analysis	Nov 2008	£110
Diabetes Drug Pipeline Competitor Analysis	Nov 2008	£1,070
Enzyme Replacement & Enhancement Therapies (ERT) Competitor Analysis	Nov 2008	£225
Stakeholder Opinions: Diabetic Renal Disease	Nov 2008	£2,315
Interferon Competitor Analysis	Nov 2008	£355
Emerging Diabetes Drugs Competitor Analysis	Nov 2008	£535
Peroxisome Proliferator-Activated Receptor (PPAR) Agonists Competitor Analysis	Nov 2008	£270
Dipeptidyl peptidase IV (DPP-IV) Inhibitors Competitor Analysis	Nov 2008	£135
Cancer Vaccines Market Forecasts, New Developments and Pipeline Analysis	Nov 2008	£2,400
Stakeholder Insight: Chronic Leukemias Is there room left for improvement?	Nov 2008	£8,070
Pipeline and Commercial Insight: Anxiety Disorders Viable indication for antipsychotics companies	Nov 2008	£8,070
GLP-1 Receptor Agonists Competitor Analysis	Nov 2008	£180
Global Radiation Therapy Market: 2008 Edition	Nov 2008	£545
Pipeline Insight: Molecular Targeted Cancer Therapies More pipeline activity, less product differentiation	Nov 2008	£8,070
The Global Pain Market 2008-2023	Nov 2008	£1,499
Who's Developing What in Drug Delivery?	Oct 2008	£595
c-MET/HGF Inhibitors Competitor Analysis	Oct 2008	£225
European Cancer IVD Market	Oct 2008	£3,910
World Gastrointestinal Disorders Market 20082023	Oct 2008	£1,499
Human Growth Hormone (hGH) Competitor Analysis	Oct 2008	£355
Insulin Competitor Analysis	Oct 2008	£355
The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities	Sep 2008	£2,305
Burden Of Disease Database	Sep 2008	£500
Currently Druggable in Prostate Cancer A Drug Target Competitive Analysis	Sep 2008	£1,780
HDL Raising Therapies Competitor Analysis	Sep 2008	£225
Cancer Drug Resistance 2008	Sep 2008	£1,675
CNS Drug Discoveries: Depression	Aug 2008	£595
CNS Drug Discoveries: what the future holds 2008 FULL REPORT	Aug 2008	£1,795
Currently Druggable in Breast Cancer A Drug Target Competitive Analysis	Aug 2008	£1,780
Toll-Like Receptor (TLR) Agonists & Antagonists Competitor Analysis	Aug 2008	£355
Global Cancer Treatment Forecast to 2012	Aug 2008	£960
CNS Drug Discoveries: Multiple Sclerosis	Aug 2008	£595
Antiviral Antibodies Competitor Analysis	Jul 2008	£180
Cytology and HPV Testing World Markets	Jul 2008	£2,105
Cancer Biomarkers Adoption Is Driving Growth	Jul 2008	£2,255
Alzheimers Disease Antibodies Competitor Analysis	Jul 2008	£89
Cancer Personalized Medicine 2008	Jul 2008	£2,425
Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights)	Jun 2008	£3,910
Emerging Trends in Cancer Therapies (Small Molecule Drugs and Biologicals) (Technical Insights)	Jun 2008	£3,910
European Lung Cancer Therapeutics Markets	Jun 2008	£3,910